Article: MORE EVIDENCE OF VALDOXAN SUPERIOR ANTIDEPRESSANT EFFICACY IN DEPRESSED PATIENTS.

MEDIA RELEASE PR35973

(Full text of statement. Contact details below.)

Further Evidence of Valdoxan(R) Superior Antidepressant Efficacy in Depressed Patients

ISTANBUL, Sept. 15 /PRNewswire-AsiaNet -- Further evidence of the superior antidepressant efficacy of Valdoxan(R) Thymanax(R) (agomelatine) over conventional selective serotonin reuptake inhibitors (SSRIs) and serotonin noradrenalin reuptake inhibitor (SNRI) antidepressants was presented today at the Servier satellite symposium on the occasion of the 22nd European College of Neuropsychopharmacology (ECNP) Congress, with educational financial support provided by Servier. The new data ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!